Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00465764 · ClinicalTrials.gov registry record · Phase 2
Tolerance and Development of Healthy, Term Infants
A Phase 2 study of Healthy, sponsored by Abbott Nutrition.
- Completed
- Registry status
- Phase 2
- Development phase
- 115
- Enrollment target
- 2
- Study locations
NCT00465764: Completed Phase 2 study of Healthy, sponsored by Abbott Nutrition.
NCT00465764 is a Phase 2 study of Healthy that has completed, run by Abbott Nutrition. The registered enrollment target is 115 participants, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower). The trial reports 2 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00465764, a Phase 2 study of Healthy, has completed, sponsored by Abbott Nutrition.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 115 participants
- Enrollment target
- 2
- Study locations
Study Summary
To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.
Conditions Studied
Interventions
- OTHER Alternate protein infant formula
- OTHER Standard infant formula
Study Locations (2)
Nebraska
- Midwest Children's Health Research Institute - Lincoln
Texas
- Children's Nutrition Research Center, Baylor College of Medicine - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 115 participants |
| Start Date | 2007-04 |
| Est. Completion | 2008-06 |
| Phase | Phase 2 |
What the finished NCT00465764 record still lists
NCT00465764 is an interventional study that assigns participants to a tested intervention. The registered 115 participants enrollment target is mid-sized for trials with a published cap, below the 647-participant average among 1,090 other Healthy trials with a reported enrollment target (82% lower).
The record links to 1 condition, with Healthy appearing as the primary indexed condition, and to 2 interventions - of which Alternate protein infant formula is the first listed.
NCT00465764 reports a single indexed study location in Nebraska, Texas.
Frequently Asked Questions
What is clinical trial NCT00465764 about?
NCT00465764 is a clinical study titled "Tolerance and Development of Healthy, Term Infants". To compare the tolerance and early bone status of healthy, term infants fed formulas during the first three months of life.
What is the current status of trial NCT00465764?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 115 participants. The study started on 2007-04. Estimated completion is 2008-06.
What conditions does trial NCT00465764 study?
This clinical trial studies the following conditions: Healthy.
What interventions are being tested in trial NCT00465764?
The interventions under investigation include: Alternate protein infant formula (OTHER), Standard infant formula (OTHER).
Who is sponsoring clinical trial NCT00465764?
This trial is sponsored by Abbott Nutrition, which has 89 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00465764 being conducted?
This trial has 2 study locations across Nebraska, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Healthy
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00465764's enrollment target sits among peer trials
115 200th of 1090 higher than 891 of 1,090 other Healthy trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Healthy trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Nasal Treatment for COVID-19
RECRUITING · Phase 2
-
Viral Mucosal Reprogramming
RECRUITING · Phase 2
-
Effects of an Antioxidant Supplement on Blood Vessel Health
RECRUITING · Phase 2
-
Atenolol for the Prevention of Osteoporosis (APO)
ACTIVE NOT RECRUITING · Phase 2
-
Effectiveness of Aquamin® in Mitigating Halitosis
ACTIVE NOT RECRUITING · Phase 2
-
Effects of Nitrite on Blood Vessel Dilation in Normal Volunteers
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02346929 · 115 participants · NA
Hematoma Block for Distal Radius Fracture
- NCT03394365 · 115 participants · Phase 3
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
- NCT03907475 · 115 participants · Phase 2
Durvalumab in Combination With Chemotherapy in Treating Patients With Advanced Solid Tumors, DURVA+ Trial
- NCT05086692 · 115 participants · Phase 1
A Beta-only IL-2 ImmunoTherapY Study
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia